You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Varilrix:

  • Equivalent of 1 case of chickenpox every minute in England and Wales.[1]
  • Chickenpox is most often a mild disease but it can lead to serious complications, hospitalisations and even death.[2]
  • 20% of parents want to privately vaccinate their children against chickenpox.[3]
  • Varilrix now protects your patients from 9 months of age against chickenpox.[4]

Protect you patients' future from chickenpox

Discover why using Varilrix should reassure you that you have protected your patient's future from the risks of chickenpox.

Guidelines

Order your Varilrix vaccine

Our vaccines ordering website is packed with features designed to save you time and help you manage your GSK vaccines purchases more effectively

Varilrix chickenpox disease

Chickenpox disease awareness campaign

Chickenpox is seen as a normal part of growing up, but it doesn’t have to be. To find out more about how to deliver this message to your patients, visit: www.spotchickenpox.com

 

References:

  1. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol. 2003;70 (Suppl 1):S9-14.
  2. Bonanni P et al. Varicella vaccination in Europe–taking the practical approach. BMC Med 2009; 7(26):1–12.
  3. Market research conducted by Healthcare Research Worldwide. Understanding parents’ perspectives on chickenpox in the UK. July 2016. Funded by GSK
  4. Varilrix SmPC, available at http://www.medicines.org.uk/emc/medicine/9787, Last accessed October 2017.

Varilrix is a registered trademark of the GlaxoSmithKline group of companies